secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001628280-23-027927
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q2 net revenue $793M (+9% YoY), net income flat $14M; Adj. EBITDA $171M (+14%); FY guidance narrowed
--------------------------------------------------------------------------------

- Net revenue $793.3M, +9.0% YoY; non-acquired net revenue growth 8.7%.
- Net income attributable $14.0M (flat YoY); Adjusted EBITDA $171.0M (+14.0%).
- Year-to-date cash flow from ops $226.6M (up from $169.9M); free cash flow $54.8M (up from $15.6M).
- FY2023 guidance narrowed: net revenue $3.16-3.20B (prior $3.16-3.24B); Adj. EBITDA $650-680M (prior $650-710M).
- Planned CEO transition: Crispin Teufel to join as CEO in September 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828023027927/0001628280-23-027927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828023027927/ahco-20230808.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-027927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer